首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1947900

細胞裂解與破碎市場分析及預測（至2035年）：依類型、產品、服務、技術、應用、最終用戶、製程及模式分類

Cell Lysis and Disruption Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Process, Mode

出版日期: 2026年02月11日 | 出版商:

Global Insight Services | 英文 354 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

細胞裂解和破碎市場預計將從2024年的62億美元成長到2034年的147億美元，複合年成長率約為9.8%。該市場涵蓋用於破碎細胞以釋放其內容物進行分析或進一步處理的技術和產品。該市場在生物技術、製藥和研究領域至關重要，可用於蛋白質萃取、DNA/RNA分離和細胞分析。技術創新著重於提高效率、擴充性以及維持生物分子的完整性。生物製藥研發的增加和個人化醫療的進步正在推動市場成長，其特點是對自動化和高通量解決方案的強勁需求。

受生物技術和藥物研發進步的推動，細胞裂解和破碎市場正經歷強勁成長。以細分市場來看，基於試劑的方法因其高效性和在實驗室環境中的易用性而表現最佳。在該細分市場中，酶解方法因其特異性和溫和的細胞破碎特性而脫穎而出，能夠保留細胞成分以供後續分析。機械破碎方法緊隨其後，其中珠磨和高壓均質法因其在大體積樣品處理方面的高效性而佔據主導。自動化細胞裂解系統發展勢頭強勁，反映出研究和臨床應用中對高通量和可重複結果的需求日益成長。耗材細分市場，包括專用試劑和試劑盒，也因即用型解決方案需求的不斷成長而呈現顯著成長動能。微流體和聲波裂解等先進技術的整合有望進一步增強市場動態，並為創新和成長提供豐厚的機會。

市場區隔
按類型	機械裂解、化學裂解、酵素解、熱裂解、超音波裂解、滲透裂解、界面活性劑裂解
產品	設備、試劑、試劑盒及耗材
服務	客製化細胞裂解服務、諮詢服務、維護服務、安裝服務
科技	高壓均質化、珠磨、超音波、凍融、微流化
目的	蛋白質萃取、細胞器分離、核酸萃取、代謝物萃取
最終用戶	生技公司、製藥公司、學術研究機構、診斷檢查室
過程	批量處理，連續處理
模式	全自動、半自動、手動

受策略定價和創新產品推出的影響，細胞裂解和破碎市場正經歷市場佔有率的動態變化。主要企業正致力於透過提供適用於各種應用的高級解決方案來擴展產品系列，從而增強其競爭優勢。定價策略日趨激進，企業也積極尋求在新興市場拓展基本客群。新技術的引入正在推動市場需求，尤其是在生物技術和製藥等對精準性和效率要求極高的行業。這種不斷變化的市場環境的特徵是研發投入不斷增加，預示著未來成長前景光明。細胞裂解和破碎市場的競爭日益激烈，主要企業相互參考以保持市場優勢。監管因素，尤其是在北美和歐洲，透過強制執行確保產品安全性和有效性的標準，在塑造市場動態發揮關鍵作用。企業正透過投資合規和認證流程來應對這些法規，這對於市場准入和擴張至關重要。此外，策略聯盟和併購也推動了市場覆蓋範圍和技術能力的提升，進一步增強了競爭格局。這項綜合分析突顯了創新和法規結構所驅動的市場潛力。

主要趨勢和促進因素：

細胞裂解和破碎市場正經歷強勁成長，這主要得益於生物技術和生命科學研究的進步。關鍵趨勢包括對個人化醫療日益成長的需求，這需要高效的細胞裂解技術來進行生物標記發現和藥物開發。此外，癌症和感染疾病研究活動的激增也推動了對先進細胞破碎技術的需求。另一個關鍵促進因素是政府對研發投入的增加。這種資金支持正在加速細胞裂解方法的創新，包括機械和化學破碎技術。生物製藥行業的成長也進一步推動了市場擴張，因為各公司都在努力最佳化生產流程並提高產品產量。此外，實驗室中自動化和高通量系統的整合正在簡化工作流程，減少人為錯誤並提高效率。這種技術進步為市場參與者開發先進的細胞裂解儀器創造了有利機會。此外，細胞裂解技術在蛋白質體學和基因組學等領域的廣泛應用也開闢了新的成長機會，尤其是在研究基礎設施快速發展的新興市場。

市場規模及預測：依類型
- 機械溶解
- 化學溶解
- 酵素解
- 熱熔化
- 超音波溶解
- 滲透溶解
- 界面活性劑溶解
市場規模及預測：依產品分類
- 裝置
- 試劑
- 成套工具
- 消耗品
市場規模及預測：依服務分類
- 客製化細胞裂解服務
- 諮詢服務
- 維護服務
- 安裝服務
市場規模及預測：依技術分類
- 高壓均質化
- 珠磨機加工
- 超音波
- 凍融
- 微流控技術
市場規模及預測：依應用領域分類
- 蛋白質萃取
- 細胞器分離
- 核酸萃取
- 代謝物萃取
市場規模及預測：依最終用戶分類
- 生技公司
- 製藥公司
- 學術研究機構
- 診斷檢查室
市場規模及預測：依製程分類
- 批量處理
- 連續加工
市場規模及預測：按模式
- 自動的
- 半自動
- 手動的

第5章區域分析

北美洲
- 美國
- 加拿大
- 墨西哥
拉丁美洲
- 巴西
- 阿根廷
- 其他拉丁美洲地區
亞太地區
- 中國
- 印度
- 韓國
- 日本
- 澳洲
- 台灣
- 亞太其他地區
歐洲
- 德國
- 法國
- 英國
- 西班牙
- 義大利
- 其他歐洲地區
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 南非
- 撒哈拉以南非洲
- 其他中東和非洲地區

第6章市場策略

需求與供給差距分析
貿易和物流限制
價格、成本和利潤率趨勢
市場滲透率
消費者分析
法規概述

第7章競爭訊息

市場定位
市場占有率
競爭基準
主要企業的策略

第8章公司簡介

Bertin Technologies
Covaris
Omni International
Microfluidics
Avestin
Qsonica
Parr Instrument Company
Constant Systems
Bio Spec Products
Stansted Fluid Power
Glen Mills
Hielscher Ultrasonics
Sonics and Materials
Emerson Process Management
IKA Works
Fisher Scientific
Precellys
Labman Automation
BBI Solutions
SP Scientific

第9章：關於我們

簡介目錄

Product Code: GIS325712

Cell Lysis and Disruption Market is anticipated to expand from $6.2 billion in 2024 to $14.7 billion by 2034, growing at a CAGR of approximately 9.8%. The Cell Lysis and Disruption Market encompasses technologies and products designed to break open cells, releasing their contents for analysis or further processing. This market is vital for biotechnology, pharmaceuticals, and research sectors, facilitating protein extraction, DNA/RNA isolation, and cell analysis. Innovations focus on efficiency, scalability, and preserving biomolecule integrity. Increasing biopharmaceutical R&D and advancements in personalized medicine are propelling market growth, with a keen emphasis on automated and high-throughput solutions.

The Cell Lysis and Disruption Market is experiencing robust growth, propelled by advancements in biotechnology and pharmaceutical research. Among the segments, the reagent-based methods are top-performing, driven by their efficiency and ease of use in laboratory settings. Within this sub-segment, enzymatic lysis stands out due to its specificity and gentle cell disruption, preserving cellular components for further analysis. Mechanical disruption methods follow closely, with bead milling and high-pressure homogenization leading the charge due to their effectiveness in processing large sample volumes. Automated cell lysis systems are gaining momentum, reflecting the increasing need for high-throughput and reproducible results in research and clinical applications. The consumables segment, including specialized reagents and kits, is also witnessing significant traction, attributed to the growing demand for ready-to-use solutions. The integration of advanced technologies, such as microfluidics and acoustic lysis, is expected to further enhance market dynamics, offering lucrative opportunities for innovation and growth.

Market Segmentation
Type	Mechanical Lysis, Chemical Lysis, Enzymatic Lysis, Thermal Lysis, Ultrasonic Lysis, Osmotic Lysis, Detergent Lysis
Product	Instruments, Reagents, Kits, Consumables
Services	Custom Cell Lysis Services, Consultation Services, Maintenance Services, Installation Services
Technology	High-pressure Homogenization, Bead Milling, Sonication, Freeze-thaw, Microfluidization
Application	Protein Extraction, Cell Organelle Isolation, Nucleic Acid Extraction, Metabolite Extraction
End User	Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes, Diagnostic Laboratories
Process	Batch Processing, Continuous Processing
Mode	Automated, Semi-automated, Manual

The Cell Lysis and Disruption Market is witnessing a dynamic shift in market share, influenced by strategic pricing and innovative product launches. Key players are focusing on expanding their portfolios with advanced solutions that cater to diverse applications, enhancing their competitive edge. Pricing strategies are becoming more aggressive, aiming to capture a larger customer base in emerging markets. The introduction of novel technologies is driving demand, particularly in sectors such as biotechnology and pharmaceuticals, where precision and efficiency are paramount. This evolving landscape is marked by increased investments in research and development, signaling a promising trajectory for future growth. Competition within the Cell Lysis and Disruption Market is intensifying, with leading companies benchmarking against each other to maintain market dominance. Regulatory influences, particularly in North America and Europe, play a critical role in shaping market dynamics, enforcing standards that ensure product safety and efficacy. Companies are navigating these regulations by investing in compliance and certification processes, which are crucial for market entry and expansion. The competitive landscape is further characterized by strategic alliances and mergers, enhancing market reach and technological capabilities. This comprehensive analysis underscores the market's potential, driven by innovation and regulatory frameworks.

Geographical Overview:

The Cell Lysis and Disruption Market is witnessing substantial growth across various regions, each exhibiting unique characteristics. North America leads the market, driven by significant advancements in biotechnology and increasing research activities. The region benefits from a robust healthcare infrastructure and substantial funding for life sciences research. Europe follows closely, with strong investments in biotechnology and pharmaceutical sectors fostering market expansion. The region's focus on innovation and technological advancements enhances its market potential. In Asia Pacific, the market is expanding rapidly due to growing investments in biotechnology and increasing demand for personalized medicine. Emerging economies in the region, such as China and India, are at the forefront of market growth, driven by government initiatives and a burgeoning biotechnology industry. Latin America and the Middle East & Africa are emerging markets with growing potential. Latin America is experiencing increased investments in biotechnology, while the Middle East & Africa are recognizing the importance of biotechnology in driving economic growth and healthcare advancements.

Global tariffs and geopolitical tensions are significantly influencing the Cell Lysis and Disruption Market, particularly in East Asia. Japan and South Korea are strengthening their domestic biotechnological capabilities to mitigate tariff impacts and reliance on external suppliers. China, facing trade barriers, is accelerating its focus on self-sufficiency and innovation in bio-manufacturing technologies. Taiwan remains a pivotal player due to its advanced manufacturing prowess but is geopolitically sensitive to US-China dynamics. The parent market is witnessing robust growth, driven by biopharmaceutical advancements, yet is susceptible to supply chain disruptions. By 2035, the market is expected to evolve with enhanced regional collaborations and technological innovations. Concurrently, Middle East conflicts pose risks to global supply chains and energy prices, potentially affecting operational costs and market stability.

Key Trends and Drivers:

The Cell Lysis and Disruption Market is experiencing robust growth, fueled by advancements in biotechnology and life sciences research. A key trend is the increasing demand for personalized medicine, which necessitates efficient cell lysis techniques for biomarker discovery and drug development. The market is also witnessing a surge in research activities related to cancer and infectious diseases, driving the need for sophisticated cell disruption technologies. Another significant driver is the rise in government funding and investments in research and development. This financial support is accelerating innovations in cell lysis methods, such as mechanical and chemical disruption techniques. The growing biopharmaceutical industry is further propelling market expansion, as companies strive to optimize production processes and enhance product yields. Moreover, the integration of automation and high-throughput systems in laboratories is streamlining workflows, reducing manual errors, and increasing efficiency. This technological evolution is creating lucrative opportunities for market players to develop advanced cell lysis equipment. Additionally, the expanding applications of cell lysis in fields like proteomics and genomics are opening new avenues for growth, particularly in emerging markets where research infrastructure is rapidly evolving.

Research Scope:

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

1 Executive Summary

1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes

2 Market Highlights

2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Services
2.4 Key Market Highlights by Technology
2.5 Key Market Highlights by Application
2.6 Key Market Highlights by End User
2.7 Key Market Highlights by Process
2.8 Key Market Highlights by Mode

3 Market Dynamics

3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
- 3.10.1 PORTER's 5 Forces Model
- 3.10.2 ANSOFF Matrix
- 3.10.3 4P's Model
- 3.10.4 PESTEL Analysis

4 Segment Analysis

4.1 Market Size & Forecast by Type (2020-2035)
- 4.1.1 Mechanical Lysis
- 4.1.2 Chemical Lysis
- 4.1.3 Enzymatic Lysis
- 4.1.4 Thermal Lysis
- 4.1.5 Ultrasonic Lysis
- 4.1.6 Osmotic Lysis
- 4.1.7 Detergent Lysis
4.2 Market Size & Forecast by Product (2020-2035)
- 4.2.1 Instruments
- 4.2.2 Reagents
- 4.2.3 Kits
- 4.2.4 Consumables
4.3 Market Size & Forecast by Services (2020-2035)
- 4.3.1 Custom Cell Lysis Services
- 4.3.2 Consultation Services
- 4.3.3 Maintenance Services
- 4.3.4 Installation Services
4.4 Market Size & Forecast by Technology (2020-2035)
- 4.4.1 High-pressure Homogenization
- 4.4.2 Bead Milling
- 4.4.3 Sonication
- 4.4.4 Freeze-thaw
- 4.4.5 Microfluidization
4.5 Market Size & Forecast by Application (2020-2035)
- 4.5.1 Protein Extraction
- 4.5.2 Cell Organelle Isolation
- 4.5.3 Nucleic Acid Extraction
- 4.5.4 Metabolite Extraction
4.6 Market Size & Forecast by End User (2020-2035)
- 4.6.1 Biotechnology Companies
- 4.6.2 Pharmaceutical Companies
- 4.6.3 Academic and Research Institutes
- 4.6.4 Diagnostic Laboratories
4.7 Market Size & Forecast by Process (2020-2035)
- 4.7.1 Batch Processing
- 4.7.2 Continuous Processing
4.8 Market Size & Forecast by Mode (2020-2035)
- 4.8.1 Automated
- 4.8.2 Semi-automated
- 4.8.3 Manual

5 Regional Analysis

5.1 Global Market Overview
5.2 North America Market Size (2020-2035)
- 5.2.1 United States
  - 5.2.1.1 Type
  - 5.2.1.2 Product
  - 5.2.1.3 Services
  - 5.2.1.4 Technology
  - 5.2.1.5 Application
  - 5.2.1.6 End User
  - 5.2.1.7 Process
  - 5.2.1.8 Mode
- 5.2.2 Canada
  - 5.2.2.1 Type
  - 5.2.2.2 Product
  - 5.2.2.3 Services
  - 5.2.2.4 Technology
  - 5.2.2.5 Application
  - 5.2.2.6 End User
  - 5.2.2.7 Process
  - 5.2.2.8 Mode
- 5.2.3 Mexico
  - 5.2.3.1 Type
  - 5.2.3.2 Product
  - 5.2.3.3 Services
  - 5.2.3.4 Technology
  - 5.2.3.5 Application
  - 5.2.3.6 End User
  - 5.2.3.7 Process
  - 5.2.3.8 Mode
5.3 Latin America Market Size (2020-2035)
- 5.3.1 Brazil
  - 5.3.1.1 Type
  - 5.3.1.2 Product
  - 5.3.1.3 Services
  - 5.3.1.4 Technology
  - 5.3.1.5 Application
  - 5.3.1.6 End User
  - 5.3.1.7 Process
  - 5.3.1.8 Mode
- 5.3.2 Argentina
  - 5.3.2.1 Type
  - 5.3.2.2 Product
  - 5.3.2.3 Services
  - 5.3.2.4 Technology
  - 5.3.2.5 Application
  - 5.3.2.6 End User
  - 5.3.2.7 Process
  - 5.3.2.8 Mode
- 5.3.3 Rest of Latin America
  - 5.3.3.1 Type
  - 5.3.3.2 Product
  - 5.3.3.3 Services
  - 5.3.3.4 Technology
  - 5.3.3.5 Application
  - 5.3.3.6 End User
  - 5.3.3.7 Process
  - 5.3.3.8 Mode
5.4 Asia-Pacific Market Size (2020-2035)
- 5.4.1 China
  - 5.4.1.1 Type
  - 5.4.1.2 Product
  - 5.4.1.3 Services
  - 5.4.1.4 Technology
  - 5.4.1.5 Application
  - 5.4.1.6 End User
  - 5.4.1.7 Process
  - 5.4.1.8 Mode
- 5.4.2 India
  - 5.4.2.1 Type
  - 5.4.2.2 Product
  - 5.4.2.3 Services
  - 5.4.2.4 Technology
  - 5.4.2.5 Application
  - 5.4.2.6 End User
  - 5.4.2.7 Process
  - 5.4.2.8 Mode
- 5.4.3 South Korea
  - 5.4.3.1 Type
  - 5.4.3.2 Product
  - 5.4.3.3 Services
  - 5.4.3.4 Technology
  - 5.4.3.5 Application
  - 5.4.3.6 End User
  - 5.4.3.7 Process
  - 5.4.3.8 Mode
- 5.4.4 Japan
  - 5.4.4.1 Type
  - 5.4.4.2 Product
  - 5.4.4.3 Services
  - 5.4.4.4 Technology
  - 5.4.4.5 Application
  - 5.4.4.6 End User
  - 5.4.4.7 Process
  - 5.4.4.8 Mode
- 5.4.5 Australia
  - 5.4.5.1 Type
  - 5.4.5.2 Product
  - 5.4.5.3 Services
  - 5.4.5.4 Technology
  - 5.4.5.5 Application
  - 5.4.5.6 End User
  - 5.4.5.7 Process
  - 5.4.5.8 Mode
- 5.4.6 Taiwan
  - 5.4.6.1 Type
  - 5.4.6.2 Product
  - 5.4.6.3 Services
  - 5.4.6.4 Technology
  - 5.4.6.5 Application
  - 5.4.6.6 End User
  - 5.4.6.7 Process
  - 5.4.6.8 Mode
- 5.4.7 Rest of APAC
  - 5.4.7.1 Type
  - 5.4.7.2 Product
  - 5.4.7.3 Services
  - 5.4.7.4 Technology
  - 5.4.7.5 Application
  - 5.4.7.6 End User
  - 5.4.7.7 Process
  - 5.4.7.8 Mode
5.5 Europe Market Size (2020-2035)
- 5.5.1 Germany
  - 5.5.1.1 Type
  - 5.5.1.2 Product
  - 5.5.1.3 Services
  - 5.5.1.4 Technology
  - 5.5.1.5 Application
  - 5.5.1.6 End User
  - 5.5.1.7 Process
  - 5.5.1.8 Mode
- 5.5.2 France
  - 5.5.2.1 Type
  - 5.5.2.2 Product
  - 5.5.2.3 Services
  - 5.5.2.4 Technology
  - 5.5.2.5 Application
  - 5.5.2.6 End User
  - 5.5.2.7 Process
  - 5.5.2.8 Mode
- 5.5.3 United Kingdom
  - 5.5.3.1 Type
  - 5.5.3.2 Product
  - 5.5.3.3 Services
  - 5.5.3.4 Technology
  - 5.5.3.5 Application
  - 5.5.3.6 End User
  - 5.5.3.7 Process
  - 5.5.3.8 Mode
- 5.5.4 Spain
  - 5.5.4.1 Type
  - 5.5.4.2 Product
  - 5.5.4.3 Services
  - 5.5.4.4 Technology
  - 5.5.4.5 Application
  - 5.5.4.6 End User
  - 5.5.4.7 Process
  - 5.5.4.8 Mode
- 5.5.5 Italy
  - 5.5.5.1 Type
  - 5.5.5.2 Product
  - 5.5.5.3 Services
  - 5.5.5.4 Technology
  - 5.5.5.5 Application
  - 5.5.5.6 End User
  - 5.5.5.7 Process
  - 5.5.5.8 Mode
- 5.5.6 Rest of Europe
  - 5.5.6.1 Type
  - 5.5.6.2 Product
  - 5.5.6.3 Services
  - 5.5.6.4 Technology
  - 5.5.6.5 Application
  - 5.5.6.6 End User
  - 5.5.6.7 Process
  - 5.5.6.8 Mode
5.6 Middle East & Africa Market Size (2020-2035)
- 5.6.1 Saudi Arabia
  - 5.6.1.1 Type
  - 5.6.1.2 Product
  - 5.6.1.3 Services
  - 5.6.1.4 Technology
  - 5.6.1.5 Application
  - 5.6.1.6 End User
  - 5.6.1.7 Process
  - 5.6.1.8 Mode
- 5.6.2 United Arab Emirates
  - 5.6.2.1 Type
  - 5.6.2.2 Product
  - 5.6.2.3 Services
  - 5.6.2.4 Technology
  - 5.6.2.5 Application
  - 5.6.2.6 End User
  - 5.6.2.7 Process
  - 5.6.2.8 Mode
- 5.6.3 South Africa
  - 5.6.3.1 Type
  - 5.6.3.2 Product
  - 5.6.3.3 Services
  - 5.6.3.4 Technology
  - 5.6.3.5 Application
  - 5.6.3.6 End User
  - 5.6.3.7 Process
  - 5.6.3.8 Mode
- 5.6.4 Sub-Saharan Africa
  - 5.6.4.1 Type
  - 5.6.4.2 Product
  - 5.6.4.3 Services
  - 5.6.4.4 Technology
  - 5.6.4.5 Application
  - 5.6.4.6 End User
  - 5.6.4.7 Process
  - 5.6.4.8 Mode
- 5.6.5 Rest of MEA
  - 5.6.5.1 Type
  - 5.6.5.2 Product
  - 5.6.5.3 Services
  - 5.6.5.4 Technology
  - 5.6.5.5 Application
  - 5.6.5.6 End User
  - 5.6.5.7 Process
  - 5.6.5.8 Mode

6 Market Strategy

6.1 Demand-Supply Gap Analysis
6.2 Trade & Logistics Constraints
6.3 Price-Cost-Margin Trends
6.4 Market Penetration
6.5 Consumer Analysis
6.6 Regulatory Snapshot

7 Competitive Intelligence

7.1 Market Positioning
7.2 Market Share
7.3 Competition Benchmarking
7.4 Top Company Strategies

8 Company Profiles

8.1 Bertin Technologies
- 8.1.1 Overview
- 8.1.2 Product Summary
- 8.1.3 Financial Performance
- 8.1.4 SWOT Analysis
8.2 Covaris
- 8.2.1 Overview
- 8.2.2 Product Summary
- 8.2.3 Financial Performance
- 8.2.4 SWOT Analysis
8.3 Omni International
- 8.3.1 Overview
- 8.3.2 Product Summary
- 8.3.3 Financial Performance
- 8.3.4 SWOT Analysis
8.4 Microfluidics
- 8.4.1 Overview
- 8.4.2 Product Summary
- 8.4.3 Financial Performance
- 8.4.4 SWOT Analysis
8.5 Avestin
- 8.5.1 Overview
- 8.5.2 Product Summary
- 8.5.3 Financial Performance
- 8.5.4 SWOT Analysis
8.6 Qsonica
- 8.6.1 Overview
- 8.6.2 Product Summary
- 8.6.3 Financial Performance
- 8.6.4 SWOT Analysis
8.7 Parr Instrument Company
- 8.7.1 Overview
- 8.7.2 Product Summary
- 8.7.3 Financial Performance
- 8.7.4 SWOT Analysis
8.8 Constant Systems
- 8.8.1 Overview
- 8.8.2 Product Summary
- 8.8.3 Financial Performance
- 8.8.4 SWOT Analysis
8.9 Bio Spec Products
- 8.9.1 Overview
- 8.9.2 Product Summary
- 8.9.3 Financial Performance
- 8.9.4 SWOT Analysis
8.10 Stansted Fluid Power
- 8.10.1 Overview
- 8.10.2 Product Summary
- 8.10.3 Financial Performance
- 8.10.4 SWOT Analysis
8.11 Glen Mills
- 8.11.1 Overview
- 8.11.2 Product Summary
- 8.11.3 Financial Performance
- 8.11.4 SWOT Analysis
8.12 Hielscher Ultrasonics
- 8.12.1 Overview
- 8.12.2 Product Summary
- 8.12.3 Financial Performance
- 8.12.4 SWOT Analysis
8.13 Sonics and Materials
- 8.13.1 Overview
- 8.13.2 Product Summary
- 8.13.3 Financial Performance
- 8.13.4 SWOT Analysis
8.14 Emerson Process Management
- 8.14.1 Overview
- 8.14.2 Product Summary
- 8.14.3 Financial Performance
- 8.14.4 SWOT Analysis
8.15 IKA Works
- 8.15.1 Overview
- 8.15.2 Product Summary
- 8.15.3 Financial Performance
- 8.15.4 SWOT Analysis
8.16 Fisher Scientific
- 8.16.1 Overview
- 8.16.2 Product Summary
- 8.16.3 Financial Performance
- 8.16.4 SWOT Analysis
8.17 Precellys
- 8.17.1 Overview
- 8.17.2 Product Summary
- 8.17.3 Financial Performance
- 8.17.4 SWOT Analysis
8.18 Labman Automation
- 8.18.1 Overview
- 8.18.2 Product Summary
- 8.18.3 Financial Performance
- 8.18.4 SWOT Analysis
8.19 BBI Solutions
- 8.19.1 Overview
- 8.19.2 Product Summary
- 8.19.3 Financial Performance
- 8.19.4 SWOT Analysis
8.20 SP Scientific
- 8.20.1 Overview
- 8.20.2 Product Summary
- 8.20.3 Financial Performance
- 8.20.4 SWOT Analysis